Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | BLM | P54132 | 2/20 | 0.53 |
| ▸ | ATM | Q13315 | 2/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | HSPA5 | P11021 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 4/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | GSR | P00390 | 2/20 | 0.44 |
| ▸ | GABBR2 | O75899 | 2/20 | 0.43 |
| ▸ | GABBR1 | Q9UBS5 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4143769 | 0.88 | ALDH1A1 (0.51) | ALDH1A1TSHRMAPK1MEN1KMT2A | |
| SCHEMBL917208 | 0.86 | ALDH1A1 (0.50) | ALDH1A1TSHRMAPK1MEN1KMT2A | |
| SCHEMBL31489807 | 0.86 | ALDH1A1 (0.50) | ALDH1A1TSHRMAPK1MEN1KMT2A | |
| SCHEMBL29475419 | 0.86 | ALDH1A1 (0.50) | ALDH1A1TSHRMAPK1MEN1KMT2A | |
| SCHEMBL15151745 | 0.81 | GAA (0.46) | ALDH1A1TSHRMAPK1MEN1KMT2A | |
| SCHEMBL12904884 | 0.81 | ALDH1A1 (0.51) | ALDH1A1TSHRMAPK1MEN1KMT2A | |
| SCHEMBL9174814 | 0.80 | ERN1 (0.56) | MAPTLMNAERN1 | |
| SCHEMBL39559 | 0.80 | ALDH1A1 (0.63) | ALDH1A1TSHRMAPK1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL918378 | 0.80 | ALDH1A1 (0.50) | ALDH1A1TSHRMAPK1MEN1KMT2A | |
| SCHEMBL10080181 | 0.80 | GAA (0.45) | ALDH1A1TSHRMAPK1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130137841-A1 | SELF-ASSEMBLED MULTI-NUCLEAR CATALYST FOR OLEFIN POLYMERIZATION | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2013-05-30 | — | — | US | disclosed |
| EP-2550308-A1 | SELF-ASSEMBLED MULTI-NUCLEAR CATALYST FOR OLEFIN POLYMERIZATION | Agency For Science, Technology And Research (SG) | 2013-01-30 | — | — | EP | disclosed |
| WO-2011119116-A1 | SELF-ASSEMBLED MULTI-NUCLEAR CATALYST FOR OLEFIN POLYMERIZATION | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-09-29 | — | — | WO | disclosed |
| US-6903043-B2 | Chiral polymeric salen catalyst, and a process for preparing chiral compounds from racemic epoxides by using them | RSTECH CO., LTD. (KR) | 2005-06-07 | — | — | US | disclosed |
| US-20040054201-A1 | Chiral polymeric salen catalyst, and a process for preparing chiral compounds from racemic epoxides by using them | RSTECH CO., LTD. (KR) | 2004-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040054201-A1 | Chiral polymeric salen catalyst, and a process for preparing chiral compounds from racemic epoxides by using them | EPHX2, GNE, EPHX1 | ALDH1A1 156/4885TSHR 4864/4885MAPK1 4504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.